Mabel Ryder

Mayo Clinic — United States

Medicine · Health Sciences

29h-index5.7kcitations166works5.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Thyroid Cancer Diagnosis and Treatment(104), Cancer Immunotherapy and Biomarkers(17), Computational Drug Discovery Methods(14), Cancer-related Molecular Pathways(13), BRCA gene mutations in cancer(10)

Publications165 total

Table S3 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S6 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Figure S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Outcomes of Peptide Receptor Radionuclide Therapy with <sup>177</sup> Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma
Journal of Nuclear Medicine·2025
Figure S1 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S5 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S1 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Figure S4 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S4 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Figure S3 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
MON-404 Fine Needle Aspiration of Thyroid Nodules Using the Bethesda System: An Institutional Experience at a Large Academic Center
Journal of the Endocrine Society·2025Open Access
Neoadjuvant pembrolizumab in combination with dabrafenib and trametinib (DTP) for <i>BRAF</i> V600E-mutated anaplastic thyroid cancer ( <i>BRAF</i> m-ATC): A multicenter phase 2 trial.
Journal of Clinical Oncology·2025· 4 cited
Quantification of Initial Symptom Relief Following Ultrasound-Guided Radiofrequency Ablation of Benign Thyroid Nodules
Ultrasound Quarterly·2025
Survival in patients with pituitary carcinoma
Endocrine Abstracts·2025
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement
The Lancet Diabetes & Endocrinology·2025· 13 citedOpen Access
3988 Outcomes in anaplastic thyroid carcinoma after spatially fractionated radiotherapy
Radiotherapy and Oncology·2025
Response to Letter to the Editor From Zhang et al: “Cabozantinib Plus Ipilimumab/Nivolumab in Patients with Previously Treated Advanced Differentiated Thyroid Cancer”
The Journal of Clinical Endocrinology & Metabolism·2025
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024
Journal of the National Comprehensive Cancer Network·2024· 74 cited
Pemetrexed‐carboplatin salvage therapy in advanced thyroid cancers
Head & Neck·2024· 5 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

James A. Fagin(13), Keith C. Bible(12), Ronald Ghossein(9), Ashish V. Chintakuntlawar(9), John C. Morris(9), Jeffrey A. Knauf(8), Crystal Hilger(8), Lisa A. Kottschade(5), Anupam Kotwal(5), John A. Thompson(4), Bryan J. Schneider(4), Julie R. Brahmer(4), Philippe Armand(4), Lihua E. Budde(4), Marianne Davies(4), Nisha Mohindra(4), Anthony J. Olszanski(4), Olalekan O. Oluwole(4), Sandip Pravin Patel(4), Sunil Reddy(4)